Analyst Ratings for Taysha Gene Therapies (TSHA) [Neutrals]

TSHA Rating Summary

TSHA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TSHA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $45.41 (+126.6%) * Over Last 12-Mos
Rating Score: 9.1 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/19/2020 Goldman Sachs
» Updated 3/4/2021
Salveen Richter New Coverage Neutral
(N/A)
36.00
(34.00)
21.05
(20.04)
-4.8% Details
Like TSHA Ratings? Also take a look at ORTX, NVTA

TSHA Ratings News